Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to explore to what degree, if any, Jet lidocaine will reduce or alleviate pain, as compared to Jet normal saline, in children undergoing needle insertion in the Pediatric Emergency Department (PED). If effective, Jet lidocaine would afford a novel rapidly acting local anesthesic for children in the PED.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

1. Age 5 - 18 years

2. Evaluation and treatment requiring needle insertion in <60 minutes (Patient is not a candidate for EMLA cream)

3. Parent or patient consent, and child assent

Exclusion Criteria:

1. Age <5 years or >18 years

2. Children eligible for or receiving EMLA cream

3. Significant blunt or penetrating trauma requiring rapid evaluation/resuscitation (GCS<15)

4. Unstable shock

5. Altered sensorium or intoxication

6. History of allergy to Lidocaine

7. Neurologic deficit involving a lack of sensation in area of insertion

8. Developmental delay so as not to understand pain scale